OOIR: Observatory of International Research

Papers

(The TQCC of European Neuropsychopharmacology is 0. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-04-01 to 2025-04-01.)

Article	Citations
Valproate's impact on future generations — A call for stricter guidelines for maternal and paternal use	310
Disease-wide association study uncovers disease continuum network of unipolar depression	280
Retinal structure and its relationship with premorbid, clinical, and cognitive variables in young Spanish patients with early course schizophrenia spectrum disorders	103
Emotional intelligence and neurocognition profiles in first-episode psychosis: A two-year follow-up study	85
A specific GPR56/ADGRG1 splicing isoform is associated with antidepressant response in major depressive disorder	73
Lack of transparency on baseline pharmacological treatments in Clinical High-Risk for psychosis (CHR-P) may degrade precision: A systematic review and meta-analysis	65
Whole-brain functional neuroimaging correlates of cognitive flexibility impairments in people with mental disorders: A transdiagnostic coordinate-based meta-analysis	61
3D imaging and geometric morphometrics of facial dysmorphology and asymmetry indicate gestational timings of dysmorphogenesis in schizophrenia and bipolar disorder	56
The role of esketamine in persistent long COVID with predominant psychiatric manifestations	54
Exploring the link between functional connectivity of ventral tegmental area and physical fitness in schizophrenia and healthy controls	53
P.0160 Clinical and demographic features in delusional disorder: a descriptive study from Turkey	53
Expert consensus recommendations on the use of randomized clinical trials for drug approval in psychiatry- comparing trial designs	51
Clozapine dosing patterns and clinical outcomes in patients with treatment resistant schizophrenia	50
TU16. BRAINXCAN IDENTIFIES BRAIN FEATURES ASSOCIATED WITH BEHAVIORAL AND PSYCHIATRIC TRAITS USING LARGE SCALE GENETIC AND IMAGING DATA	46
Sodium nitroprusside enhances the antipsychotic-like effect of olanzapine but not clozapine in the conditioned avoidance response test in rats	45
Opioid use and misuse in Europe: COVID-19 new challenges?	44
The long-term effects of adolescent Δ9-tetrahydrocannabinol on brain structure and function assessed through neuroimaging techniques in male and female rats	43
Charting the proteome landscape in major psychiatric disorders: From biomarkers to biological pathways towards drug discovery	43
P.0012 The costs of alcohol hangover for the Dutch economy: impact of absenteeism and presenteeism	43
Comparative effectiveness of mood stabilizers and antipsychotics in the prevention of hospitalization after lithium discontinuation in bipolar disorder	40
Citizen participation processes in mental health: Does it help or worsen things?	38
Self-reported neurocognitive symptoms during COVID-19 lockdown and its associated factors in a sample of psychiatric patients. Results from the BRIS-MHC study	37
W92. POLYGENIC RISK SCORES INDICATES GENETIC OVERLAP BETWEEN METHAMPHETAMINE USE AND OTHER PSYCHIATRIC DISORDERS	36
Minor physical anomalies in schizophrenia and first-degree relatives in comparison to healthy controls: A systematic review and meta-analysis	36
T32. GENETIC ARCHITECTURE OF BIPOLAR SPECTRUM DISORDERS IN NEARLY 102,000 LATINO ANCESTRY INDIVIDUALS	36

Corrigendum to “34th ECNP Congress – Lisbon 2021 Hybrid. [34th ECNP Congress – Lisbon 2021 Hybrid. 53S1. December 2021]” P.0576 Knockdown of 5-HT1A receptor silencer Freud-2 in the frontal cortex affe	36
F8. THE DEVELOPMENTAL LANDSCAPE OF NEUROPSYCHIATRIC GENOMICS IN AFRICA	34
85. EXTENSIVE GENETIC INTERACTIONS (EPISTASIS) IDENTIFIED FOR ALCOHOL USE DISORDER IN A HIGH-RISK AMERICAN INDIAN POPULATION	34
T78. GENE-ENVIRONMENT INTERACTION STUDY ON THE CORRELATES FOR PSYCHOTIC EXPERIENCES IN THE UK BIOBANK	34
EXPLORING MENTAL HEALTH STIGMA IN THE CONTEXT OF PSYCHIATRIC GENETICS: INSIGHTS FROM THE ISPG STIGMA REDUCTION SIG SURVEY	34
69. LARGE-SCALE GENETIC INVESTIGATION OF TRAIT-BASED RESILIENCE USING THE CONNOR-DAVIDSON RESILIENCE SCALE (CD-RISC)	32
W6. DEVELOPMENT OF PSYCHIATRIC GENOMICS RESEARCH IN AFRICA: A SYSTEMATIC LITERATURE REVIEW	32
40. NOVEL FINDINGS FROM TRANSCRIPTOME-WIDE ASSOCIATION STUDIES OF 5 MAJOR PSYCHIATRIC DISORDERS USING ANCESTRALLY DIVERSE GENE EXPRESSION MODELS	32
POLYGENIC ARCHITECTURE AND DISEASE RISK PREDICTION	31
EVALUATING THE IMPACT OF BIOLOGICAL SEX ON ADHD PRESENTATION, PREVALENCE, AND GENETIC RISK	30
39. POLYGENIC SCORES FOR PSYCHIATRIC DISORDERS PREDICT QUANTITATIVE SYMPTOM SCORES IN THE POPULATION LARGELY DUE TO THE PERVASIVE GENETIC INFLUENCE OF GENERAL PSYCHOPATHOLOGY (P)	29
42. STRESS EXPOSURE DYNAMICALLY REGULATES EQTL ACTIVITY IN THE POST-MORTEM BRAIN AND IN HIPSC-DERIVED NEURONS	29
W1. MULTI-ANCESTRY EPIGENETIC INVESTIGATION OF GENERALIZED ANXIETY DISORDER IN THE MILLION VETERAN PROGRAM	29
6. DECIPHERING NEURONAL NETWORK DEFECTS IN SCHIZOPHRENIA USING MICROFLUIDIC CULTURES	29
NEW INSIGHTS INTO THE GENETIC ETIOLOGY AND THERAPEUTIC TARGETS OF SCHIZOPHRENIA	28
60. SEX-STRATIFIED SINGLE-CELL ANALYSIS UNCOVERS GENE EXPRESSION DIFFERENCES IN SCHIZOPHRENIA, BIPOLAR DISORDER, AND AUTISM	28
COORDINATED EPISTASIS DETECTS HETEROGENOUS PATHWAYS ACROSS PSYCHIATRIC DISORDERS AND COMORBIDITIES	27
W11. TRANSDIAGNOSTIC AND FAMILIAL INSIGHTS INTO PREFRONTAL CORTEX FUNCTIONALITY: A RESTING-STATE FNIRS STUDY	27
LEVERAGING GENETIC PLEIOTROPY IN DRUG TARGET DISCOVERY FOR PSYCHIATRIC DISORDERS	26
INTRODUCING MIND: THE METHYLATION, IMAGING AND NEURODEVELOPMENT CONSORTIUM	26
11. ESTABLISHING THE MOLECULAR FOUNDATION OF BRAIN ANATOMY IN LIVING INDIVIDUALS	26
41. CHARACTERIZING FUNCTIONAL CONVERGENCE OF COMMON POLYGENIC VARIATION IN NEUROPSYCHIATRIC DISORDER RISK GENES	24
79. DECIPHERING THE GENETIC ARCHITECTURE OF TOURETTE SYNDROME: A LARGE-SCALE GWAS REVEALS NOVEL RISK LOCI AND HIGHLIGHTS BRAIN REGION SPECIFICITY	24
W47. PSYCHIATRIC AND CARDIOMETABOLIC COMORBIDITIES OF TREATMENT-RESISTANT DEPRESSION	24
33. ASSOCIATIONS OF POLYGENIC RISKS FOR SCHIZOPHRENIA, BIPOLAR DISORDER, AND DEPRESSION WITH SYMPTOM DIMENSIONS AND TREATMENT OUTCOMES IN SCHIZOPHRENIA	24
T13. GENETIC ASSOCIATIONS OF ICD-DERIVED PSYCHIATRIC DIAGNOSES WITH SELF-REPORTED MENTAL HEALTH PHENOTYPES IN THE UK BIOBANK	23
W82. ASSOCIATION OF GENETIC VARIATION IN ANTIDIABETIC DRUG TARGET GENES AND PSYCHIATRIC DISORDERS: A MENDELIAN RANDOMIZATION STUDY	23
56. GENOME WIDE ASSOCIATION STUDY OF SCHIZOPHRENIA IN THE NEUROPSYCHIATRIC GENETICS IN AFRICAN POPULATION-PSYCHOSIS (NEUROGAP-PSYCHOSIS) STUDY	23
W44. THE INFLUENCE OF INFLAMMATORY CYTOKINE GENETIC VARIANTS ON SYMPTOM SEVERITY IN THE PSYCOURSE STUDY	23
W73. GENETIC AND SOCIOENVIROMENTAL CORRELATES OF SYMPTOM DIMENSIONS ACROSS THE PSYCHOSIS SPECTRUM AT BASELINE AND 10-YEAR FOLLOW-UP	22
T56. DIP2A, HIGHLY EXPRESSED GENE IN THE CEREBELLUM, IS ASSOCIATED WITH A WIDE RANGE OF PSYCHIATRIC SYMPTOMS (DELAYED SPEECH, AUTISM SPECTRUM DISORDER AND SPECIFIC LEARNING DISABILITIES)	22
T84. AN INVESTIGATION ON GENETIC MECHANISMS UNDER CLINICAL HETEROGENEITY IN SCHIZOPHRENIA	21
T51. LARGE-SCALE WHOLE-GENOME SEQUENCING ANALYSIS REVEALS A HIGHER-THAN-EXPECTED PREVALENCE OF C9ORF72 REPEAT EXPANSION ALLELES ASSOCIATED WITH SPECIFIC HAPLOTYPE STRUCTURE IN THE GENERAL POPULATION	21
W14. POLYGENIC PREDICTION OF CONDITIONED FEAR RESPONSES	20
T58. EXPLORATION OF GENETIC AND CLINICAL HETEROGENEITY IN AUTISM BY CLUSTERING GENES BASED ON BULK AND SINGLE-CELL TRANSCRIPTOMIC DATA	20
T27. FEMA-GWAS: FAST AND EFFICIENT MIXED-EFFECTS ALGORITHM FOR DISCOVERY OF GENOME-WIDE AGE-DEPENDENT EFFECTS	20
T47. A MULTI-OMIC QTL ANALYSIS OF MAJOR DEPRESSIVE DISORDER	20
W59. DE NOVO PROMOTER VARIANTS CONTRIBUTE TO AUTISM SPECTRUM DISORDER RISK VIA TOPOLOGICALLY ASSOCIATING DOMAINS	19
F22. EPIGENETIC INSIGHTS INTO OBSESSIVE-COMPULSIVE DISORDER THROUGH A META-EWAS APPROACH	19
F18. ROLE OF PSYCHIATRIC-ASSOCIATED SNVS IN THE EARLY ADULTHOOD: INSIGHTS FROM LONGITUDINAL NEUROIMAGING	18
F41. AMBER: ANTIDEPRESSANT MEDICATIONS: BIOLOGY, EXPOSURE AND RESPONSE	18
F42. MOLECULAR EFFECTS OF ADVERSE LIFE EVENTS IN A DIVERSE POPULATION OF POSTPARTUM WOMEN	18
PRECISION AND ACCURACY IN SINGLE-CELL RNA-SEQ	18
W72. GENETIC INSIGHTS INTO COGNITIVE FUNCTION: A GWAS OF ASIAN ANCESTRY USING MULTI-TRAIT ANALYSIS	18
F51. EPIGENOME-WIDE ASSOCIATION STUDY OF READING AND LANGUAGE TRAITS	17
70. GENOME-WIDE ASSOCIATION STUDY OF BORDERLINE PERSONALITY DISORDER IDENTIFIES SIX GENETIC RISK LOCI AND REVEALS SHARED GENETIC RISK WITH OTHER MENTAL DISORDERS AND RISK FACTORS	17
27. HOW “DYSLEXIA GENES” INFLUENCE BRAIN STRUCTURE AND CONNECTIVITY?	17
TREATMENT RESISTANCE IN SCHIZOPHRENIA: UTILITY OF POLYGENIC RISK SCORES	17
31. SCHIZOPHRENIA GENETIC RISK AND CELL-SPECIFIC DIFFERENTIAL EXPRESSION ARE LINKED TO GENE REGULATORY NETWORKS FOR CELL MATURATION THAT PATTERN THE TRANSCRIPTIONAL ARCHITECTURE OF THE HUMAN CORTEX	17
SCIENCE COMMUNICATION: THE IMPORTANCE OF LANGUAGE IN A DIVERSE WORLD	17

W76. INVESTIGATION OF DE NOVO MUTATIONS IN SCHIZOPHRENIA AFFECTED INDIAN FAMILIES	17
T48. WHOLE-GENOME DNA METHYLATION SEQUENCING IN BLOOD IDENTIFIES DIFFERENTIAL METHYLATION IN PARKINSON'S DISEASE IN THE CHINESE HAN POPULATION	17
T59. THE CONNECTION BETWEEN ADHD AND ACADEMIC ACHIEVEMENT IN CONTRASTING ENVIRONMENTS	16
W35. SHARED GENETIC ARCHITECTURE BETWEEN INFLAMMATORY PROCESSES AND DEPRESSION: EXPLORING GENETIC CORRELATIONS, OVERLAP AND CAUSALITY	16
T16. THE ASSOCIATION BETWEEN DEPRESSION POLYGENICITY AND DISEASE ACTIVITY AND DISABILITY WORSENING IN MULTIPLE SCLEROSIS	16
T21. COMMON AND RARE GENETIC ARCHITECTURE OF COMORBIDITY BETWEEN CARDIOVASCULAR DISEASES AND SEVERE MENTAL DISORDERS	16
F16. BRAIN CARTOGRAPHY OF GENOME-WIDE POLYGENIC RISK THROUGH SPATIAL TRANSCRIPTOMICS PREDICTS BRAIN STRUCTURE IN MAJOR PSYCHIATRIC DISORDERS	15
T96. DELTA-9-TETRAHYDROCANNABINOL MODULATES IMMUNOGENOMIC FUNCTION AT SINGLE CELL RESOLUTION USING 10X MULTIOME PROFILING: IN VIVO HUMAN SUBJECT STUDY	15
DRUG REPOSITIONING ANALYSIS IDENTIFIED HUNDREDS OF NOVEL COMPOUNDS ASSOCIATED WITH TOBACCO USE DISORDER	14
59. UNVEILING CELL-TYPE-SPECIFIC CHANGES IN SCHIZOPHRENIA: INSIGHTS FROM CELL COMPOSITION, GENE EXPRESSION, AND GENETIC RISK ENRICHMENT	14
F75. PREDICTION OF TREATMENT-RESISTANT SCHIZOPHRENIA USING REAL-WORLD DATA AND MULTIMODAL ANALYTICAL TOOLS	14
T100. CHILD SUBCORTICAL BRAIN VOLUMES: THE INTERACTION BETWEEN GENETIC RISK AND MATERNAL PSYCHOLOGICAL DISTRESS DURING PREGNANCY	14
UPDATE FROM THE “PEDIGREE-BASED WHOLE GENOME SEQUENCING OF AFFECTIVE AND PSYCHOTIC DISORDERS" CONSORTIUM	14
T29. SPATIAL-MOLECULAR SEX DIFFERENCES IN THE HUMAN VENTROMEDIAL AND ARCUATE HYPOTHALAMUS	14
F30. DECONSTRUCTION OF MENTAL DISABILITY CLASSIFICATION STRATIFIES CHRONIC PSYCHIATRIC AND NEUROLOGICAL OUTCOME AND IDENTIFIES OUTCOME-RELEVANT ACUTE FACTORS FOR PATIENTS WITH TRAUMATIC BRAIN INJURY	14
F97. DIFFERENTIAL EXPRESSION OF MICRORNAS UPON IN VITRO LITHIUM AND VALPROATE EXPOSURE TO BIPOLAR DISORDER PATIENTS-DERIVED LCLS	14
F35. INVESTIGATING GENETIC RISK FOR PSYCHOSIS IN BIPOLAR DISORDER IN INDIA USING POLYGENIC SCORES	14
F70. INTEGRATION OF MULTI-OMICS SUMMARY DATA REVEALS THE ROLE OF N6-METHYLADENOSINE METHYLATION IN NEUROPSYCHIATRIC DISORDERS	14
T83. CONTRIBUTION OF COPY NUMBER VARIANTS ON ANTIPSYCHOTIC TREATMENT RESPONSE IN HAN CHINESE PATIENTS WITH SCHIZOPHRENIA	14
F38. THE CLINICAL UTILITY OF POLYGENIC SCORES FOR PREDICTING LITHIUM TREATMENT RESPONSE IN PATIENTS WITH BIPOLAR DISORDER: CHARTING THE PATH FORWARD	14
P.0516 Genotype rs25531 polymorphisms and quality in peer relationships adjust the neural response of the anterior prefrontal cortex to cry	13
First episode psychosis longitudinal cohort studies: The CIBERSAM FEP cohort	13
The clinical perspective on late-onset depression in European real-world treatment settings	13
INNATE AND ADAPTIVE IMMUNITY IN PSYCHIATRY: INSIGHTS FROM GENETIC ASSOCIATION STUDIES AND PERIPHERAL BLOOD IMMUNOPHENOTYPING	13
Deciphering the impact of metabolic anomalies in relation to severe mental illness	13
Cognitive impairment networks in Alzheimer's disease: Analysis of three double-blind randomized, placebo-controlled, clinical trials of donepezil	13
Stress, mental disorder and ketamine as a novel, rapid acting treatment	13
Psychotropic drug utilization patterns in pregnant women with bipolar disorder: A 16-year population-based cohort study	13
Psilocybin intoxication did not affect daytime or sleep-related declarative memory consolidation in a small sample exploratory analysis	13
Prescribing therapeutic apps within National Health Services: The critical role of evaluation and monitoring	13
A randomized controlled trial of add-on naproxen, simvastatin and their combination for the treatment of schizophrenia or schizoaffective disorder	12
Outcomes associated with different vaccines in individuals with bipolar disorder and impact on the current COVID-19 pandemic- a systematic review	12
Precision psychiatry: The complexity of personalizing antipsychotic dosing	12
F103. A GENOME-WIDE ASSOCIATION STUDY OF USING SUBSTANCES TO COPE WITH DEPRESSION AND ANXIETY IN THE UK BIOBANK AND POLYGENIC ASSOCIATIONS WITH ALCOHOL USE DISORDER SEVERITY.	12
The substantia nigra in the pathology of schizophrenia: A review on post-mortem and molecular imaging findings	12
Transcriptional biomarkers of response to pharmacological treatments in severe mental disorders: A systematic review	12
Non-prescribed use of gabapentinoids: Mechanisms, predisposing factors, associated hazards and clinical management	12
P.0835 Synergistic effects of lysergic acid diethylamide (LSD) and cannabidiol (CBD)	12
Comparative effectiveness of antipsychotic monotherapy and polypharmacy in schizophrenia patients with clozapine treatment: A nationwide, health insurance data-based study	12
SYMPTOM-LEVEL GENETIC MODELLING OF DEPRESSION AND ANXIETY	11
CHARACTERIZING RACISM IN PSYCHIATRIC DIAGNOSES	11
PUSHING THE ENVELOPE WITH POLYGENIC RISK SCORES IN PSYCHIATRIC GENETICS: WHETHER, WHEN, AND HOW TO IMPLEMENT	11
ANALYSIS OF COPY NUMBER VARIATION ACROSS THE MAJOR PSYCHIATRIC DISORDERS: BIPOLAR DISORDER, SCHIZOPHRENIA, AND AUTISM SPECTRUM DISORDER	11
ASSESSING THE EFFECTS OF RARE COPY NUMBER VARIANTS ON PSYCHIATRIC SYMPTOMS AND COGNITIVE ABILITY IN ∼1M INDIVIDUALS	11
SHARED AND DISTINCT GENETIC INFLUENCES BETWEEN COGNITIVE DOMAINS AND PSYCHIATRIC DISORDER RISK BASED ON GENOME-WIDE DATA	11
Whole-brain structural and functional neuroimaging of individuals who attempted suicide and people who did not: A systematic review and exploratory coordinate-based meta-analysis	11
CLINICAL RELEVANCE OF GENOTYPE-PHENOTYPE ANALYSES WITHIN BIPOLAR DISORDER AND ACROSS THE MOOD AND PSYCHOSIS SPECTRUM	11
ADVERSARIAL COLLABORATION IN GENOMICS: TURNING DISAGREEMENT INTO CONSTRUCTIVE DIALOGUE	11
Transcriptome meta-analysis of valproic acid exposure in human embryonic stem cells	11
Contents	11
PHENOME-WIDE GENETIC CORRELATION AND CAUSALITY OF COVID-19 SEVERITY HIGHLIGHTS OVERLAP WITH SUBSTANCE-USE TRAITS	11
Society Calendar	11
ECNP Calendar of Meetings	11
The Mechanism of Akathisia - Comments on Wu et al. Eur Neuropsychopharmacol 2023;72:40–49	11
9. ULTRA-RARE GENETIC VARIATION IN THE EPILEPSIES: A WHOLE-EXOME SEQUENCING STUDY OF 32K INDIVIDUALS	10
24. WHOLE EXOME SEQUENCING META-ANALYSIS OF DEPRESSION SUGGESTS SUBTLE ROLE FOR FUNCTIONAL VARIANTS IN KNOWN GENETIC ASSOCIATION LOCI	10
ECNP Calendar of Meetings	10
Editorial Board	10
THE 4TH PSYCHIATRIC GENOMICS CONSORTIUM GRANT (2021-26): AIMS AND INTENTIONS	10
6. CONTRIBUTION OF COPY NUMBER VARIANTS TO SCHIZOPHRENIA IN EAST ASIAN POPULATIONS	10
23. MASSIVELY PARALLEL, IN VIVO PROFILING OF MDD SNP EFFECTS ON TRANSCRIPTION ACROSS AGE, SEX, AND CELL TYPE	10
29. MAPPING ASSOCIATIONS BETWEEN ATTENTION-DEFICIT/HYPERACTIVITY DISORDER GENETIC LIABILITY, ATTENTION-DEFICIT/HYPERACTIVITY DISORDER SYMPTOMS, AND BEHAVIORAL AND NEURAL CORRELATES OF RESPONSE INHIBIT	10
Comparing the pharmacology and pharmacokinetics of antipsychotics: Choosing an antipsychotic and dosing a long-acting injectable	10
MENTAL HEALTH PHENOTYPING FOR GENETIC STUDIES	10
8. PHENOTYPIC MANIFESTATIONS OF GENETIC LIABILITY TO NEUROTICISM ACROSS CHILDHOOD: A UK PROSPECTIVE BIRTH COHORT STUDY	10
27. USING A TRIO-BASED GENETIC DESIGN FOR INVESTIGATING THE AETIOLOGY OF ATTENTION DEFICIT HYPERACTIVITY DISORDER (ADHD)	10
38. LATENT SUBTYPES OF MANIC OR IRRITABLE EPISODE SYMPTOMS IN TWO POPULATION-BASED COHORTS	10
ECNP Calendar of Meetings	10
33. SHARED GENETIC DETERMINANTS BETWEEN THE BRAIN FUNCTIONAL CONNECTOME AND PSYCHIATRIC DISORDERS	10
P.0204 Meye web-app: translational and real-time pupillometry for studying cognitive and emotional processing	9
DNA METHYLATION PARTIALLY MEDIATES THE RELATIONSHIP BETWEEN TIME-DEPENDENT CHILDHOOD ADVERSITY AND DEPRESSIVE SYMPTOMS IN ADOLESCENCE	9
Technology exceptionalism in medicine: Is it time to rethink the paradigm?	9
Editorial Board	9
T46. DO SEX AND GENDER MODIFY THE EFFECT OF APOE-Ɛ4 ON NEUROCOGNITIVE IMPAIRMENT? A MULTI-ANCESTRY ANALYSIS IN THE UK BIOBANK	9
T54. ASSOCIATION BETWEEN TELOMERE LENGTH AND CORTICAL THICKNESS IN ADULTS WITH ADHD	9
T61. CLINICAL, GENETIC AND NEUROIMAGING ASPECTS OF ATTENTION-DEFICIT/HYPERACTIVITY DISORDER COURSES THROUGH MIDLIFE	9
Contents	9
A COMPARISON OF THREE PHENOTYPE DEFINITIONS FOR MENTAL HEALTH CONDITIONS IN THE MILLION VETERAN PROGRAM	9
P.0166 Suppression of the inflammatory response in schizophrenia hipsc-derived neural progenitors: a gene-environment interaction study	9
T51. MACHINE LEARNING CLASSIFICATION OF ATTENTION DEFICIT HYPERACTIVITY DISORDER USING GENOMIC CONTEXT INFORMED GENOTYPE DATA AND WITHIN-MODEL ANCESTRY ADJUSTMENT	9

T58. CIRCADIAN ACTIVITY AND ADHD: INTEGRATING GENOMIC DATA WITH WEARABLE TECHNOLOGY	9
T43. INSIGHTS INTO THE GENETICS OF PERINATAL DEPRESSION VIA POLYGENIC SCORES	9
ECNP Calendar of Meetings	9
EXTENSIVE POLYGENIC OVERLAP BETWEEN SCHIZOPHRENIA AND CORTICAL BRAIN STRUCTURE	9
T28. COMPARISON OF QUANTITATIVE FAMILY HISTORY WITH POLYGENIC SCORES IN FAMILIES OF BIPOLAR PROBANDS	9
Is it time to change the term negative symptoms?	9
P.0190 Epigenetic mechanisms underlying the stress-induced activation of serum/glucocorticoid regulated kinase 1	9
P.0221 A rapid, concise and robust companion diagnostic pgx test supporting drug selection for diseases of the central nervous system	8
P.0234 Optogenetic shift of mesolimbic dopamine to tonic pattern reduces reward-seeking behavior	8
T103. INTEGRATED ANALYSIS OF RARE EXONIC VARIANTS PROVIDES ADDITIONAL INSIGHTS INTO ALCOHOL USE DISORDER RISK	8
P.0246 Transcriptomic analysis of trace amine-associated receptors (taars) mrna expression in the neurons of olfactory bulb of model animals	8
P.0262 Self-directed virtual care: a review of the evidence for current digital therapeutic methods in adult mental health patients	8
P.0270 Early structural alterations in mitochondria in adult dopamine neurons induced by conditional ablation of MFN2	8
T80. IDENTIFICATION OF CAUSAL GENES AND PUTATIVE DRUG TARGETS FOR PARKINSON'S DISEASE AND SCHIZOPHRENIA USING STATISTICAL GENETICS TECHNIQUES	8
T72. AUTOENCODER BASED CORRECTION OF POPULATION STRATIFICATION PER INDIVIDUAL SNP'S	8
T67. ASSOCIATION BETWEEN INFLAMMATORY CYTOKINE VARIANTS AND SUICIDE: AN INDIAN POPULATION-BASED STUDY	8
T70. A COMPUTATIONAL TRANSCRIPTOMICS APPROACH TO DRUG REPURPOSING IDENTIFIES NEW THERAPEUTIC CANDIDATES FOR TREATMENT OF CHRONIC PAIN	8
P.0247 Assessment of sexual behavior of taar2 and taar5 knockout mice	8
P.0254 TRPC4/5 inhibition reverses both stress-induced excessive aversion processing and attenuated reward processing in mice	8
P.0260 Optimising a human induced pluripotent stem cell system to model the effects of il-6 on early neurodevelopment	8
T87. PHENOTYPING AND IMMUNE MARKER SUB-ANALYSIS OF A NIGERIAN SCHIZOPHRENIA GWAS COHORT	8
P.0229 Characterization of positive allosteric modulators of trkb for the treatment of depression	8
P.0208 Base editing therapeutic strategies for motor neuron diseases	8
T68. INVESTIGATING TRANSGENERATIONAL EFFECTS OF MATERNAL PSYCHOLOGICAL DISTRESS THROUGH INFANT GENE EXPRESSION PROFILES IN A SOUTH AFRICAN BIRTH COHORT STUDY	8
T86. PREDICTING PSYCHOSIS: EXPLORING THE ADDITIVE AND INTERACTION EFFECTS OF GENETIC AND EPIGENETIC RISK SCORES	8
P.0244 Cannabidiol increased the seizure latency and reduced the mortality rate in the pentylenetetrazole-kindling model of epilepsy in rats	8
T99. INTERACTIONS BETWEEN FAMILY HISTORY AND ENVIRONMENTAL FACTORS IN SCHIZOPHRENIA AND BIPOLAR DISORDER	8
T101. RARE AND COMMON VARIANTS FOR PROBLEMATIC ALCOHOL USE IDENTIFY OVERLAPPING GENE NETWORKS	8
P.0235 Selectivity of taar1 partial agonist ro5263397 effects on drug- versus non-drug-related behaviors	8
T74. DUPLICATION IN THE POGZ GENE AND PSYCHIATRIC MANIFESTATIONS IN TWIN BROTHERS WITH WHITE SUTTON SYNDROME	8
F30. MENTAL HEALTH RISK AND RESILIENCE DURING THE COVID-19 PANDEMIC AMONG INDIVIDUALS AT HIGH GENETIC RISK FOR BIPOLAR DISORDER	7
F71. NETWORK OF CO-METHYLATION ASSOCIATED WITH GREY MATTER MATURATION IN HUMAN ADOLESCENCE	7
F7. THE ASSOCIATIONS BETWEEN EDUCATIONAL EXPERIENCES AND MENTAL HEALTH FROM CHILDHOOD TO YOUNG ADULTHOOD	7
WHOLE GENOME SEQUENCING	7
THE BROAD ARRAY OF COLLABORATIVE OPPORTUNITIES WITH REGENERON	7
T6. A SYSTEMATIC REVIEW AND META-ANALYSIS OF RESEARCH USING THE AUTISM POLYGENIC SCORE	7
F6. EXPLORING THE BIOLOGICAL RELATIONSHIPS BETWEEN IRON METABOLISM MARKERS AND PSYCHIATRIC DISORDERS	7
F34. CHARACTERISING ANTIDEPRESSANT USAGE BASED ON ELECTRONIC PRESCRIPTION RECORDS IN THE AUSTRALIAN GENETICS OF DEPRESSION STUDY	7
F94. SIGNIFICANT TELOMERE SHORTENING IN MALAYSIAN PATIENTS WITH SCHIZOPHRENIA: RELATIONSHIP WITH TOTAL ANTIOXIDANT CAPACITY AND OTHER COVARIATES	7
BIG DATA IN DIFFERENT STUDY DESIGNS – ALL WITH THEIR OWN BIASES	7
P.0594 Cortisol effects on brain activity and cognition (CEBAC) study: An fmri study of emotional face processing and pulsatile cortisol dynamics	7
P.0303 Preclinical models of neuropsychiatric disorders do not indicate impulsivity-related adverse effects of angiotensin II receptor blockers	7
P.0285 Regulation of the synaptic vesicle liquid phase by dynamic sh3 domain binding	7
F15. MITOCHONDRIA-ASSOCIATED GENE NETWORK-ENVIRONMENT INTERACTION EFFECT ON THE RISK FOR IMPULSIVE BEHAVIOR AND SUBSTANCE DEPENDENCE OVER THE LIFE COURSE	7
F48. INVESTIGATING POTENTIAL RELATIONSHIPS BETWEEN PIGMENTATION GENETICS AND PARKINSON'S DISEASE (PD)	7
P.0561 Chronic treatment with iloperidone affects the cytochrome P450 2D (CYP2D) protein and activity in the brain and liver	7
P.0565 Calcium salt of N-(5-hydroxynicotinoyl)-L-glutamic acid weakens depressive-like behavior and Parkinsonian syndrome in experiment on rodents	7
PLENARY PANEL: RESEARCH TO CLINICAL APPLICATION PANEL DISCUSSION	7
P.0632 The added value of cognitive behavioral therapy on quality of life in combination with pharmacotherapy in adults with ADHD	7
P.0322 Assessing the role of impulsivity in criminal recidivism: a preliminary observational study	6
P.0329 Sex-related differences in adult attention-deficit/hyperactivity disorder – an analysis of striatal resting-state functional connectivity	6
P.0316 Cannabis culture, consumption, and implicit cognition: behavioral findings from a cross-cultural neuroimaging study of dutch and american cannabis users	6
P.0383 Switching to duloxetine following inadequate antidepressant response improves symptoms and quality of life in a prospective, real-world, observational study	6
P.0350 Preference study in childhood autism spectrum disorder (asd) using childhood autism rating scale (CARS2): qualitative research and informal pilot study	6
P.0320 Depression, anxiety, psychotic-like symptoms and addiction in adolescents and adults who do and do not use cannabis	6
T15. DECODING GWAS SIGNALS: AN INTEGRATIVE METHOD FOR GENE PRIORITIZATION	6
P.0281 Cholinergic manipulations in the ventral tegmental area and hippocampal theta rhythm in urethane-anesthetized rats	6
P.0405 Enhanced inflammatory response in the brain of suicide victims is associated with a weakening of the AMPK/CREB signaling pathway	6
T35. SHARED GENETIC LIABILITY FOR ALCOHOL CONSUMPTION, ALCOHOL PROBLEMS, AND SUICIDAL BEHAVIOR: EVALUATING THE ROLE OF IMPULSIVITY	6
T60. UNDERSTANDING THE GENETIC UNDERPINNINGS OF EATING DISORDER DIAGNOSTIC TRANSITIONS	6
P.0321 Ayahuasca as a rescue treatment in depressive patients resistant to pharmacological treatment: a systematic review	6
P.0357 Effect of a combination therapy with cannabidiol and β-caryophyllene in SCN1A-A1783V mice, an experimental model of dravet syndrome	6
P.0820 Association of resilience with limbic activity during negative emotional face processing in individuals who experienced childhood maltreatment	6
P.0312 Treatment of bipolar i disorder and alcohol use disorder dual diagnosis using opioid antagonists	6
P.0391 Ultra-resistant major depression: treatment with in-esketamine on compassionate use	6
P.0356 Bariatric surgery leads to potentially favourable changes in proteins associated with neurocognitive function related to the degree of weight loss	6
T91. LARGE-SCALE ANALYSIS WITH SOFTWARE CONTAINERS IN ENIGMA-CNV – AN INTERNATIONAL WORKING GROUP TO STUDY RECURRENT COPY NUMBER VARIANTS AND BRAIN MEASURES	6
T19. THE GENETIC BASIS OF MANIC SYMPTOMS IN INDIVIDUALS WITH DEPRESSION AND ANXIETY	6
T21. WEIGHT AND BIPOLAR DISORDER: A MOLECULAR PATHWAY ANALYSIS	6
T8. TREATMENT WITH GALANTAMINE IN 15Q13.3 DELETIONS: GENOMICALLY-INFORMED PRECISION MEDICINE STRATEGIES IN NEURODEVELOPMENTAL DISORDERS	6
T67. ASSOCIATIONS BETWEEN METHYLATION AGE AND BRAIN AGE IN LATE ADOLESCENCE	6
P.0814 Effects of a web-based adapted physical activity program (e-APA) on cardiorespiratory fitness and clinical symptoms in patients with schizophrenia	6
P.0638 Comparing the psychological impact of COVID-19 pandemic between psychiatric patients and healthy subjects: an observational retrospective study from northern Italy	6
Gender Dysphoria and its associated hurdles in Pakistan	6
T87. COPY-NUMBER VARIATION IN TOURETTE SYNDROME FAMILIES, ANALYSIS OF DE NOVO AND INHERITED CNVS	6
P.0352 Avoidant/Restrictive food intake disorder in adult female treated with attachment-based therapy and cognitive behavioral therapy: case report	6
P.0688 Investigating the biological mechanisms underlying the risk of developing adolescent depression in Brazil: the IDEA Project	5
PREFRONTAL INTERNEURON GENES UNDERLIE NEUROBIOLOGICAL PROCESSES SHARED BETWEEN PSYCHIATRIC DISORDERS	5
P.0499 Impact of childhood trauma on executive functioning and emotional regulation in adults: role of stress and inflammation	5
INVESTIGATING GENETIC OVERLAP BETWEEN ANTIDEPRESSANTS AND LITHIUM RESPONSE AND TREATMENT RESISTANCE IN MAJOR DEPRESSIVE DISORDER	5
DISTINCT ASSOCIATION PATTERNS OF ABNORMAL BRAIN STRUCTURE AND FUNCTION WITH GENE EXPRESSION IN DEPRESSION	5
THE IMPACT OF ADDITIONAL RARE AND COMMON GENETIC VARIANTS TO ND-CNV CARRIER COGNITIVE OUTCOMES	5
P.0500 Investigation into the factors potentially associated with poor psychological wellbeing in italian healthcare professionals during the COVID-19 pandemic	5
P.0511 The role of sex steroids and serotonin brain dynamics in perinatal mental health	5
P.0509 Emotion de-regulation in a cohort of young europeans during the spring 2020 lockdown	5
P.0827 One-week of escitalopram administration does not change emotional and attentional responses in healthy female individuals on oral hormonal contraceptives	5
GENETIC INFLUENCES ON NEURODEVELOPMENTAL DISORDERS AND THEIR OVERLAP WITH CO-OCCURRING CONDITIONS IN CHILDHOOD AND ADOLESCENCE: A SYSTEMATIC REVIEW AND META-ANALYSIS	5
P.0847 Acute genetic depletion of brain serotonin contributes to dominant behaviour and changes in ultrasonic vocalisation in rats	5
NOVEL LOCI AND TARGET GENES INFLUENCING FUNCTIONAL SEIZURES IDENTIFIED IN A MULTI-SITE GENOME-WIDE ASSOCIATION STUDY META-ANALYSIS IN A SAMPLE OF 570,460 PATIENTS	5
Contents	5
P.0536 Oxytocin receptor gene DNA methylation as a predictor of treatment response in obsessive-compulsive disorder	5
DNA METHYLATION CHANGES ASSOCIATED WITH ECT TREATMENT	5
P.0527 Sexual dysfunction and vortioxetine: a systematic review	5
P.0683 Effect of glutamate excitotoxicity on white matter integrity in bipolar disorder: a TBSS study	5
P.0851 Fluoxetine treatment effect on photoperiodic alterations in behavior, brain serotonin and brain-derived neurotrophic factor in tumor necrosis factor knockout mice	5